Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
COSCIENS Biopharma ( (TSE:CSCI) ) has provided an announcement.
On May 8, 2026, COSCIENS Biopharma Inc. filed a Form 6-K announcing it had issued a Notice of Annual General and Special Meeting of Shareholders. The filing formalizes regulatory disclosure around the upcoming shareholder meeting and underscores the company’s adherence to U.S. and Canadian securities governance requirements.
The Annual General and Special Meeting will be held as a virtual meeting on June 17, 2026, with May 18, 2026 set as the record date for notice, voting, and beneficial ownership determination. COSCIENS will pay for delivery of proxy materials to objecting beneficial owners, signaling an effort to facilitate shareholder participation and ensure broad investor involvement in key corporate decisions.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. is a foreign private issuer in the biopharmaceutical sector, listed in the United States and subject to the Securities Exchange Act of 1934. The company’s securities are common shares identified under CUSIP 22112H101 and ISIN CA22112H1010, and it reports using Form 20-F.
Average Trading Volume: 4,413
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$8.18M
For an in-depth examination of CSCI stock, go to TipRanks’ Overview page.